Skip to content
In deliveryUnited KingdomGoodsFramework agreement£115,756,000

NHS National Framework for Transition Products (Nintedanib and Dalbavancin)

Published
Published 24 October 2025
Deadline
Closed 28 January 2026

Overview

Project title: NHS National Framework for Transition Products (Nintedanib and Dalbavancin) commencing 1st May 2026 Offer reference number: CM/TNS/25/5736 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to a maximum of 24 months. CM/TNS/25/5736 Nintedanib and Dalbavancin Lot 1 DLN/DNW: 01/05/2026 to 30/09/2027 (17 months) Lot 2 DLS/DNE: 01/05/2026 to 31/05/2027 (13 months) Lot 3 DCE/DSW: 01/05/2026 to 31/01/2027 (9 months) Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

Key details

Country
United Kingdom
Status
In delivery
Category
Goods
Estimated value
£115,756,000
Procedure
Open
Contract type
Framework agreement
SME suitable
Yes
Published
24 October 2025
Questions by
21 January 2026
Deadline
Closed
Classification (CPV)
Pharmaceutical products

Award outcome

Awarded value
£29,516,000
Award date
25 February 2026
Contract period
30 April 2026 → 30 September 2027
Winners
  • ACCORD-UK LTD
  • Baxter Healthcare Ltd
  • CELIX PHARMA LTD
  • CELIX PHARMA LTd
  • DR REDDY'S LABORATORIES (UK) LIMITED
  • Glenmark Pharmaceuticals Europe Limited
  • MILPHARM LIMITED
  • REIG JOFRE UK LIMITED
  • WOCKHARDT UK LIMITED
  • ZENTIVA PHARMA UK LIMITED

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract

    24 April 2026

    View notice ↗
  2. Contract

    25 February 2026

    View notice ↗
  3. Contract Notice

    18 December 2025

    View notice ↗
  4. Prior Information Notice

    24 October 2025

    View notice ↗

Contracting authority

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: NHS National Framework for Transition Products (Nintedanib and Dalbavancin) — won by ACCORD-UK LTD +9 — Skim